Wee Joo Chng
Professor Wee Joo Chng is the Director of the National University Cancer Institute of Singapore (NCIS) at the National University Health System, Singapore (NUHS). He is also the Deputy Director and a Senior Principal Investigator at the Cancer Science Institute (CSI), Singapore, National University of Singapore (NUS). Professor Chng is also a Professor of Medicine at the Yong Loo Lin School of Medicine, National University of Singapore. He is the current President of the Singapore Society of Haematology.
He Graduated from the University of Leeds Medical School in the United Kingdom. He has a PhD from National University of Singapore. He has fellowships from the Royal College of Physicians, Edinburgh; Academy of Medicine, Singapore; and Royal College of Pathologist, UK. His research interests focus around multiple myeloma, and the biology and therapeutics of haematologic malignancies. He is a member of many international professional committees, such as American Society of Haematology Scientific Committee on Plasma Cell Neoplasia, the International Myeloma Working Group and the Asian Myeloma Network.
Professor Chng is in the peer review committee of journals such as Blood, leukemia, Cancer Research, and Nature Genetics. He is also involved in a number of Grant Review Committees, Conference Organising Committee, Advisory Boards and Steering Committees of Global Clinical Trials. He has authored more than 170 publications in many reputed journals, such as The New England Journal of Medicine, Cancer Cell, Blood, Leukemia, Nature Medicine, and Cancer Research. Prof Chng has also authored several book chapters, actively participated in clinical trials and has delivered talks in many national and international conferences. He has won multiple awards for his research both locally and internationally including the National Medical Research Council Clinician Scientist Award, The National University of Singapore Young Researcher Award, the National Medical Excellence Award Outstanding Clinician Scientist Award and the Celgene Future Leaders in Haematology Award.